Epidemiology of neuropathic pain

Posso, Irimar de Paula; Palmeira, Cláudia Carneiro de Araújo; Vieira, Érica Brandão de Moraes

doi:10.5935/1806-0013.20160039

Cited by 20 publications

(18 citation statements)

References 55 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Regarding the surgery, the frequency of NP at the site of surgery was 24.8%, which agrees with the results found in other studies 5,6,8 . NP was considered severe by over half the patients.…”

Section: Discussionsupporting

confidence: 91%

“…An additional fact that would justify the high occurrence of NP is difficulty, of the population studied, to gain access to diagnostic services and therapeutic interventions within a reasonable period, as mentioned by another author 7 who found, among patients undergoing palliative care, a rate of occurrence of NP higher than that for patients in outpatient wards. It is also reported that the tardy commencement of treatment for cancer may increase this prevalence 16 , as the occurrence of NP is related to more advanced stages of oncologic disease 6,8 . Another result is that approximately two-thirds of the included patients were females and this data is in agreement with the high percentage of cancer of the breast of the sample 8 .…”

Section: Discussionmentioning

confidence: 99%

“…This study did not see any association between NP and the types of treatments performed, different from other studies that suggested a greater association of neuropathic harm for those people subjected to chemotherapy 8,15 . However, there was no appraisal of the chemotherapy schemes that knowingly affect the risk of dysfunction of the central nervous system 6,8,10 . One important datum found was that those patients who had a greater number of interventions (chemotherapy, radiotherapy, and surgery) had a significantly larger proportion of symptoms characteristic of NP.…”

Section: Discussionmentioning

confidence: 99%

“…Neuropathic pain (NP) can be defined as any pain that arises as a direct consequence of a lesion, or of other disorders that affect the somatosensory system 4 . Neuropathic pain (NP) occurs in between 7 and 8% of the oncologic population 5,6 . However, the lack of awareness of this theme, and of appropriate methods for the appraisal of NP, among medical professionals are a factor that contributes to the underdiagnosis of this specific ailment 1,4 .…”

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Prevalence of neuropathic pain in patients with cancer

Couceiro¹,

Lima²,

Júnior³

et al. 2018

Brazilian Journal of Pain

View full text Add to dashboard Cite

BACKGROUND AND OBJECTIVES: To evaluate the prevalence and factors associated with neuropathic pain in cancer patients METHODS: A prospective cross-sectional study conducted from August 2016 to July 2017, with 267 cancer patients above 18 years of age, with pain. Diabetic patients and patients with previous chronic pain unrelated to the current neoplasia were excluded. The demographic and disease information was obtained from the medical records and directly with the patient. The Douleur Neuropathique en 4 questions questionnaire and the numeric pain scale were later applied. RESULTS: The prevalence of neuropathic pain in the study population was 53%. The average age of patients was 55.3 years. Of the 267 patients, 76% were female. There was no significant difference in the occurrence of neuropathic pain among gender, age, histological type of cancer and type of treatment. Of the patients, 35.5% who underwent chemotherapy had neuropathic pain, and there was no statistical difference between the types of chemotherapy performed. Twenty-four patients who reported pain at the radiotherapy site were diagnosed with neuropathic pain. Of the total, 63 patients who reported pain at the surgical site, 36 were classified with neuropathic pain. An increasing trend of neuropathic pain was observed when treatments were associated. The intensity of this pain was reported as moderate to severe by the majority of patients in the various types of treatment: chemotherapy, radiotherapy, and surgery. CONCLUSION: When compared to other studies, a high prevalence of neuropathic pain was observed in more than half of the patients evaluated.

show abstract

Section: Discussionsupporting

confidence: 91%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Prevalence of neuropathic pain in patients with cancer

Couceiro¹,

Lima²,

Júnior³

et al. 2018

Brazilian Journal of Pain

View full text Add to dashboard Cite

show abstract

“…We can observe a wide variety in the prevalence of NP in the world. This is because the epidemiological studies are carried out with different methodologies, sample selection, diagnostic criteria and assessment tools, not to mention the influence of the cultural and sociodemographic diversity 8,32 . Another important factor observed in the studies on NP is that many researchers carried their research with samples composed of people with the clinical diagnosis of diabetic neuropathy.…”

Section: Discussionmentioning

confidence: 99%